
Please try another search
Dong-A Socio Holdings Co., Ltd., together with its subsidiaries, engages in the pharmaceutical business in South Korea. It operates through Holding Company; Over-the-Counter Drugs and Quai-Drugs; Biosimilars and Consignment Medicines; Logistics; Packaging Solutions; and Others segments. The company develops DA-8010 in Phase 3 clinical trial to treat overactive bladder; DMB-3115, a biosimilar of Stelara in Phase 3 clinical trial; DA-1241 in Phase 2 clinical trial for the treatment of non-alcoholic steatohepatitis; DA-1726 in Phase 1 clinical trial to treat obesity; and STP0404 for the treatment of AIDS. It also provides medical devices and equipment; healthcare solutions to customers in Bacchus, over-the-counter, consumer healthcare, and cosmetics; health functional food; contract development and manufacturing organization for biosimilar and pharmaceutical products, and oligonucleotide therapeutics; functional sports drinks under the POCARI SWEAT brand; logistics and fulfillment services; glass bottles, PET bottles, aluminum and plastic caps, and paper packaging boxes; mineral and carbonated water, and mixed drinks; and IT and construction services. In addition, the company is involved in engineering; cargo, courier, and automobile transport arrangement; transportation warehousing and leasing; real estate development; agricultural product distribution; management consulting; business management; and architectural, electric work, fire protection, and housing contracting services. Dong-A Socio Holdings Co., Ltd. was founded in 1932 and is headquartered in Seoul, South Korea.
Name | Age | Since | Title |
---|---|---|---|
Shin-Ho Kang | 97 | - | Honorary Chairperson |
Kyoung Bae Kwon | - | 2021 | Independent Non-Executive Outside Chairman |
Seung Hyun Ko | - | 2021 | Executive Director, CFO & Head of Management Support Office |
Min-Young Kim | 52 | 2017 | CEO & Executive Director |
Young-Sam Keum | - | 2022 | Independent Outside Director |
Se-Won Kwon | - | 2022 | Independent Outside Director |
Yeon-seok Jeong | - | 2025 | Non-Executive Director |
Hyun-Min Lee | 55 | 2025 | Executive Director & Head of Business Planning Office |
Young-Jin Chung | - | 2024 | Non-Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review